(Reuters) – The U.S. Food and Drug Administration has approved Elanco Animal Health’s oral drug to protect dogs against six parasitic infections, the company said on Monday.
The drug, branded as Credelio Quattro, is a single, monthly chewable tablet for dogs eight weeks of age or older, the company said.
The drug is approved for the treatment of flea and tick infestations, along with roundworm, hookworm and tapeworm infections. It is also approved to prevent flea infestations and heartworm disease in dogs.
The company expects to launch the drug in the first quarter of 2025.
(Reporting by Mariam Sunny in Bengaluru; Editing by Devika Syamnath)
